ION-283
/ Ionis
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
September 24, 2024
A Safety and Efficacy of Intrathecally Administered ION283 in Patients With Lafora Disease
(clinicaltrials.gov)
- P1/2 | N=10 | Recruiting | Sponsor: Berge Minassian
New P1/2 trial
1 to 1
Of
1
Go to page
1